US Stock MarketDetailed Quotes

ONCT Oncternal Therapeutics

Watchlist
  • 1.0500
  • -0.0200-1.87%
Trading Nov 19 11:42 ET
3.11MMarket Cap-89P/E (TTM)

Oncternal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Oncternal Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 137.500K--
--2024/Q3494.000K / 137.500K--
Aug 8, 20242024/Q2801.000K / 158.330K--
May 9, 20242024/Q1569.000K / 132.500K--
Mar 7, 20242023/Q4297.000K / 137.500K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 137.500K--
--2024/Q3494.000K / 137.500K--
Aug 8, 20242024/Q2801.000K / 158.330K--
May 9, 20242024/Q1569.000K / 132.500K--
Mar 7, 20242023/Q4297.000K / 137.500K--

Unlock Free Earnings Estimates

Oncternal Therapeutics Earnings Reports

  • Oncternal Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:32 ET

  • Oncternal Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:37 ET

  • Oncternal Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 16:25 ET

  • Oncternal Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 16:25 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 19, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data